Geneos Wealth Management Inc. Pacira Bio Sciences, Inc. Transaction History
Geneos Wealth Management Inc.
- $3.92 Billion
- Q2 2025
A detailed history of Geneos Wealth Management Inc. transactions in Pacira Bio Sciences, Inc. stock. As of the latest transaction made, Geneos Wealth Management Inc. holds 363 shares of PCRX stock, worth $8,250. This represents 0.0% of its overall portfolio holdings.
Number of Shares
363
Previous 384
5.47%
Holding current value
$8,250
Previous $9,000
11.11%
% of portfolio
0.0%
Previous 0.0%
Shares
8 transactions
Others Institutions Holding PCRX
# of Institutions
259Shares Held
51.2MCall Options Held
289KPut Options Held
130K-
Black Rock Inc. New York, NY8.01MShares$182 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.41MShares$123 Million0.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny2.4MShares$54.5 Million0.08% of portfolio
-
D. E. Shaw & Co., Inc. New York, NY2.25MShares$51.2 Million0.04% of portfolio
-
Dimensional Fund Advisors LP Austin, TX2.15MShares$48.9 Million0.01% of portfolio
About Pacira BioSciences, Inc.
- Ticker PCRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 45,824,200
- Market Cap $1.04B
- Description
- Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid ...